Potassium Carbonate → (1R,2R)-2-((6-((4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol

HRID 1847996Notes

Reaction equation

HRID 1847996 reaction equation
Br[C:2]1[N:3]=[CH:4][N:5]([CH2:7][C:8]2[CH:24]=[CH:23][C:11]3[N:12]=[C:13]([NH:15][C@@H:16]4[CH2:21][CH2:20][CH2:19][CH2:18][C@H:17]4[OH:22])[S:14][C:10]=3[CH:9]=2)[CH:6]=1.[CH3:25][N:26]1[CH:30]=[C:29](B2OC(C)(C)C(C)(C)O2)[CH:28]=[N:27]1.C([O-])([O-])=O.[K+].[K+]>COCCOC.O.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH3:25][N:26]1[CH:30]=[C:29]([C:2]2[N:3]=[CH:4][N:5]([CH2:7][C:8]3[CH:24]=[CH:23][C:11]4[N:12]=[C:13]([NH:15][C@@H:16]5[CH2:21][CH2:20][CH2:19][CH2:18][C@H:17]5[OH:22])[S:14][C:10]=4[CH:9]=3)[CH:6]=2)[CH:28]=[N:27]1

Participants

7

Conditions

Temperature
100 °C

Procedure

To a suspension of (1R,2R)-2-((6-((4-bromo-1H-imidazol-1-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol (50 mg, 0.12 mmol) from Step 7 of this Example and 1-methylpyrazole-4-boronic acid pinacol ester (51 mg, 0.25 mmol) in a mixture of DME (0.7 mL) and H2O (0.3 mL) was added K2CO3 (68 mg, 0.5 mmol). Argon was bubbled into the mixture for 5 min. To the mixture was added tetrakis(triphenylphosphine)palladium (0) (14 mg, 0.01 mmol). Argon was bubbled into the mixture for 5 min. The reaction vessel was sealed and the mixture was heated at 100° C. for 16 h. Additional portions of 1-methylpyrazole-4-boronic acid pinacol ester (51 mg, 0.25 mmol) and tetrakis(triphenylphosphine)palladium (0) (14 mg, 0.01 mmol) were added to the mixture and argon was bubbled into the mixture for 5 min. The reaction vessel was sealed and the mixture was heated at 110° C. for 4 h. The mixture was cooled to rt and partitioned between EtOAc (100 mL) and aq 1 N K2CO3 (50 mL). The EtOAc layer was separated and washed with water (50 mL) and brine (50 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by preparative reverse-phase HPLC using a mixture of water (5% CH3CN, 0.05% HCOOH) and CH3CN (0.05% HCOOH) as the mobile phase and Varian Pursuit XRs C18 column as the stationary phase to afford (1R,2R)-2-((6-((4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol (10.3 mg, 20%) as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 7.97 (d, J=7.5 Hz, 1H), 7.80 (s, 1H), 7.71 (s, 1H), 7.54-7.62 (m, 2H), 7.32 (d, J=8.3 Hz, 1H), 7.24 (s, 1H), 7.16 (dd, J=1.3, 8.3 Hz, 1H), 5.13 (s, 2H), 4.75 (brm, 1H), 3.80 (s, 3H), 3.52 (br s, 1H), 3.34 (br s, 1H), 2.04 (d, J=10.2 Hz, 1H), 1.88 (d, J=9.4 Hz, 1H), 1.55-1.66 (m, 2H), 1.10-1.33 (m, 4H). LCMS (ESI) m/z 409 (M+H)+.

Workup

  1. customArgon was bubbled into the mixture for 5 min
  2. customArgon was bubbled into the mixture for 5 min
  3. customThe reaction vessel was sealed
  4. customwas bubbled into the mixture for 5 min
  5. customThe reaction vessel was sealed
  6. temperaturethe mixture was heated at 110° C. for 4 h
  7. temperatureThe mixture was cooled to rt
  8. custompartitioned between EtOAc (100 mL) and aq 1 N K2CO3 (50 mL)
  9. customThe EtOAc layer was separated
  10. washwashed with water (50 mL) and brine (50 mL)
  11. dry with materialdried over Na2SO4
  12. filtrationfiltered
  13. concentrationconcentrated under reduced pressure
  14. customThe residue was purified by preparative reverse-phase
  15. additiona mixture of water (5% CH3CN, 0.05% HCOOH) and CH3CN (0.05% HCOOH) as the mobile phase and Varian Pursuit XRs C18 column as the stationary phase

Sources & evidence

ORD record
ord-e6bdbc1335854518871ed1632497be3a
Source dataset
uspto-grants-2015_02
Patent number
US08952058B2

Reaction notes

Loading…